Jonathan Mark Boutell

Title: The Innovative Contributions of Jonathan Mark Boutell

Introduction

Jonathan Mark Boutell is an accomplished inventor based in the United States. He is known for his work in the field of therapeutic agent discovery and analysis. His innovative approach has the potential to significantly impact the way candidate agents are characterized and evaluated.

Latest Patents

Jonathan Mark Boutell has developed a method titled "Platform For Discovery And Analysis Of Therapeutic Agents." This method includes several steps: providing a library of candidate agents attached to nucleic acid tags, contacting the library with a solid support to form an array, and screening the array with a screening agent. The process involves detecting reactions between candidate agents and the screening agent, sequencing the nucleic acid tags, and identifying the candidate agents based on their tag sequences. Although he currently holds 1 patents, his contributions to the field are noteworthy.

Career Highlights

Jonathan is currently employed at Illumina Corporation, a leading company in the field of genomics. His work at Illumina focuses on advancing technologies that enhance the discovery and analysis of therapeutic agents. His expertise and innovative mindset contribute to the company's mission of improving human health through genomics.

Collaborations

Throughout his career, Jonathan has collaborated with talented individuals such as Molly Min He and Michael Previte. These collaborations have fostered a creative environment that encourages the development of groundbreaking ideas and solutions.

Conclusion

Jonathan Mark Boutell's innovative work in therapeutic agent discovery showcases his commitment to advancing scientific knowledge and technology. His contributions, although not yet reflected in patents, highlight the importance of collaboration and innovation in the field of genomics.